Takaomi Sanda

Abstract 3336: ARID5B activates the TAL1-induced core regulatory circuit and the oncogene MYC, thereby promoting T-cell leukemogenesis

Daniel G. Tenen, Zhiyuan Gong, Wei Zhong Leong, 2018, Molecular and Cellular Biology / Genetics.

Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemia

Andrew L. Kung, Jonathan D. Licht, Alex Kentsis, 2012, Nature Medicine.

Interconnecting molecular pathways in the pathogenesis and drug sensitivity of T-cell acute lymphoblastic leukemia.

Richard S Larson, Jennifer O'Neil, Donna S Neuberg, 2010, Blood.

Targeting transcription regulation in cancer with a covalent CDK7 inhibitor

Sridhar Ramaswamy, Taebo Sim, Richard A Young, 2014, Nature.

Inactivation of LEF1 in T-cell acute lymphoblastic leukemia.

Donna Neuberg, Catriona Jamieson, Lynda Chin, 2010, Blood.

Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia.

Richard A Young, Zi Peng Fan, R. Young, 2012, Cancer cell.

The ALK(F1174L) mutation potentiates the oncogenic activity of MYCN in neuroblastoma.

Bandana Sharma, Wenchao Wang, Nathanael S Gray, 2012, Cancer cell.

Activating mutations in ALK provide a therapeutic target in neuroblastoma

D. Gary Gilliland, Stefan Fröhling, Wendy B. London, 2008, Nature.